Using the research developed from the laboratory by Matthew Campbell, Trinity College Dublin, we have developed unique technologies for controlled modulation of permeability at the blood brain barrier. Having the potential to revolutionise the treatment of neurological conditions allowing small molecules to enter the brain as treatment as well as allowing pathological molecules to be removed
| Website | https://www.junctionthx.com/ |
| Employees | 2 (2 on RocketReach) |
| Founded | 2016 |
| Technologies |
JavaScript
,
HTML
,
Nginx
+3 more
(view full list)
|
| Industry | Biotechnology Research, Biotechnology, Science and Engineering |
| Keywords | Drug Delivery, Neurological Disorders, Pharmaceutical Technology, Therapeutics, Biotechnology, Drug Development, Controlled Release, Targeted Drug Delivery, Central Nervous System, Neurology, Biopharma, Translational Research, Pharmaceutical Research, Innovative Therapies, Precision Medicine, Clinical Trials, New Drug Delivery |
Looking for a particular Junction Therapeutics employee's phone or email?
Daniella Hirons is the Exec. Director, Clinical Operations of Junction Therapeutics.
2 people are employed at Junction Therapeutics.
Junction Therapeutics is based in Dublin, Dublin.